Tardive dyskinesia: symptoms, treatment, and when to worry
Last updated September 3, 2026.
Tardive dyskinesia is involuntary, repetitive movements, usually of the face, lips, and tongue, caused by long-term use of certain medicines, most often antipsychotics. It can appear after months or years on the drug, or even after stopping it. The important thing: it is a recognized, treatable side effect, and you should never stop your antipsychotic suddenly to fix it.
What does it look like?
The movements are involuntary and repetitive: lip smacking or puckering, tongue movements or protrusion, chewing motions, grimacing, rapid blinking, and sometimes writhing movements of the fingers, arms, or legs. They typically ease in sleep and worsen with stress or distraction. The causative medicines are mainly antipsychotics, with some anti-nausea drugs like metoclopramide also implicated. Risk rises with treatment length, higher doses, older age, and certain other factors.
What actually helps?
- Report it early: new involuntary movements on an antipsychotic deserve a prompt review. Earlier recognition means more options.
- Never stop abruptly: suddenly stopping an antipsychotic can trigger relapse of the illness it treats and can temporarily worsen the movements. Any change is planned with your prescriber.
- Review the medication plan: your prescriber may adjust the dose, or switch you to an antipsychotic with lower movement-disorder risk. This is a joint decision, weighing mental health stability against the movements.
- Specific TD treatments exist: medicines called VMAT2 inhibitors (such as valbenazine and deutetrabenazine) are licensed specifically for tardive dyskinesia and reduce the movements meaningfully for many people.
- Track it: clinicians use a structured scale (the AIMS exam) to grade the movements over time, so treatment effects are measured rather than guessed.
When is it an emergency?
Tardive dyskinesia itself is not an emergency, but two situations are urgent: severe movements interfering with eating, swallowing, or breathing, and any sudden medication stop followed by agitation, confusion, or fever, which needs same-day assessment. If the underlying illness destabilizes and you have thoughts of harming yourself, call or text 988 now. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Can tardive dyskinesia go away?
Sometimes, particularly if caught early and the causative medicine is adjusted. For others the movements persist, and that is where the specific TD medicines, VMAT2 inhibitors, earn their place, reducing movements meaningfully for many patients even when the antipsychotic must continue. The realistic message: it is often improvable and treatable, and earlier review opens more doors.
Should I stop my antipsychotic if I get tardive dyskinesia?
Not on your own, and not suddenly. Abrupt stopping risks relapse of the illness the medicine controls, and can paradoxically worsen movements short-term. The right move is a planned review with your prescriber: options include dose adjustment, switching to a lower-risk antipsychotic, adding a TD-specific treatment, or a combination. Mental health stability and movement control are weighed together.
Which medicines cause tardive dyskinesia?
Mainly antipsychotics, with older ones carrying higher risk, though the newer ones carry risk too. Certain anti-nausea medicines, metoclopramide and prochlorperazine among them, can also cause it. Risk accumulates with dose and years of treatment, and is higher in older adults. If you are on any of these long-term, regular movement checks are part of good care, so ask about them.
How is tardive dyskinesia diagnosed?
Clinically: a clinician watches for the characteristic involuntary, repetitive movements, maps them to your medication history, and often scores them with a structured exam (the AIMS). Tests are sometimes used to rule out other movement disorders. There is no single blood test or scan that proves TD; the pattern plus the medication history is the diagnosis.
What treatments are approved specifically for TD?
The VMAT2 inhibitors, valbenazine and deutetrabenazine, are licensed specifically for tardive dyskinesia and have trial evidence for reducing movements. They are usually added to, not substituted for, the mental health treatment plan, and are prescribed by specialists familiar with movement side effects. Other medicines are sometimes tried, but these two are the purpose-built options.
Can tardive dyskinesia be prevented?
Partly. Using the lowest effective antipsychotic dose, reviewing regularly whether the medicine is still needed, and screening for early movements at routine appointments all reduce risk. Avoiding long-term metoclopramide where alternatives exist matters too. Once movements appear, early recognition is the practical version of prevention, because options are widest before movements are severe.